➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
AstraZeneca
Express Scripts
Medtronic
Mallinckrodt

Last Updated: October 23, 2020

DrugPatentWatch Database Preview

BROMPHENIRAMINE MALEATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Brompheniramine Maleate, and what generic alternatives are available?

Brompheniramine Maleate is a drug marketed by Alpharma Us Pharms, Kv Pharm, Pharm Assoc, Usl Pharma, Watson Labs, Barr, Ivax Sub Teva Pharms, Newtron Pharms, Nexgen Pharma Inc, Par Pharm, Pioneer Pharms, Upsher Smith Labs, Vitarine, Acella, Alkem Labs Ltd, Lannett Co Inc, Mayne Pharma Inc, Paddock Labs Llc, Taro, and Wes Pharma Inc. and is included in twenty-four NDAs.

The generic ingredient in BROMPHENIRAMINE MALEATE is brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride. There are twenty-one drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride profile page.

Summary for BROMPHENIRAMINE MALEATE
Drug patent expirations by year for BROMPHENIRAMINE MALEATE
Recent Clinical Trials for BROMPHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ache Laboratorios Farmaceuticos S.A.Phase 3
Wyeth is now a wholly owned subsidiary of PfizerN/A

See all BROMPHENIRAMINE MALEATE clinical trials

Medical Subject Heading (MeSH) Categories for BROMPHENIRAMINE MALEATE

US Patents and Regulatory Information for BROMPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms BROMPHENIRAMINE MALEATE brompheniramine maleate ELIXIR;ORAL 086936-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Alkem Labs Ltd BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 210647-001 Jul 14, 2020 AA RX No No   Start Trial   Start Trial   Start Trial
Wes Pharma Inc BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 211170-001 Jun 16, 2020 AA RX No No   Start Trial   Start Trial   Start Trial
Barr BROMPHENIRAMINE MALEATE brompheniramine maleate TABLET;ORAL 084468-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Usl Pharma BROMPHENIRAMINE MALEATE brompheniramine maleate ELIXIR;ORAL 087964-001 Jan 25, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Express Scripts
McKinsey
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.